INKT icon

MiNK Therapeutics
INKT

Overview Fund Trends Analyst Outlook Journalist POV

42 hedge funds and large institutions have $3.1M invested in MiNK Therapeutics in 2023 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

0.25% more ownership

Funds ownership: 0.18% → 0.43% (+0.25%)

Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$682K
2
+$403K
3
+$284K
4
BlackRock
BlackRock
New York
+$149K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$142K

Top Sellers

1
-$316K
2
-$129K
3
-$61.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2K
27
$1K
28
$1K
29
$733
30
$649
31
$389
32
$353
33
$225
34
$134
35
$122
36
$90
37
$65
38
$55
39
$21
40
$16
41
$13
42
$11
43
$5
44
–
45
–
1
2